In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at...
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
In honor of International Day of Women and Girls in Science, a United Nations initiative aimed at narrowing a...
The American Association for Cancer Research (AACR) recently appointed Chi Van Dang, MD, PhD, as the new editor-in-chief of...
The American Association for Cancer Research (AACR) is proud to support World Cancer Day, a yearly initiative of the...
The obesity epidemic shows no signs of abating. The World Health Organization estimates that the proportion of the world’s...
In 1993, Jon R. Katzenbach and Douglas K. Smith authored The Wisdom of Teams, a collection of observations and...
Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated...
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...